203 related articles for article (PubMed ID: 23834278)
21. Characterization and comparative studies of zebrafish and human recombinant dihydrofolate reductases--inhibition by folic acid and polyphenols.
Kao TT; Wang KC; Chang WN; Lin CY; Chen BH; Wu HL; Shi GY; Tsai JN; Fu TF
Drug Metab Dispos; 2008 Mar; 36(3):508-16. PubMed ID: 18056255
[TBL] [Abstract][Full Text] [Related]
22. Searching the "biologically relevant"conformation of dopamine: a computational approach.
Andujar SA; Tosso RD; Suvire FD; Angelina E; Peruchena N; Cabedo N; Cortes D; Enriz RD
J Chem Inf Model; 2012 Jan; 52(1):99-112. PubMed ID: 22146008
[TBL] [Abstract][Full Text] [Related]
23. Protein-drug interactions: characterization of inhibitor binding in complexes of DHFR with trimethoprim and related derivatives.
Fleischman SH; Brooks CL
Proteins; 1990; 7(1):52-61. PubMed ID: 2330368
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, biological evaluation and computational investigation of novel inhibitors of dihydrofolate reductase of opportunistic pathogens.
Bag S; Tawari NR; Degani MS; Queener SF
Bioorg Med Chem; 2010 May; 18(9):3187-97. PubMed ID: 20363634
[TBL] [Abstract][Full Text] [Related]
25. Reaction path potential for complex systems derived from combined ab initio quantum mechanical and molecular mechanical calculations.
Lu Z; Yang W
J Chem Phys; 2004 Jul; 121(1):89-100. PubMed ID: 15260525
[TBL] [Abstract][Full Text] [Related]
26. Hybrid density functional-molecular mechanics calculations for core-electron binding energies of glycine in water solution.
Niskanen J; Arul Murugan N; Rinkevicius Z; Vahtras O; Li C; Monti S; Carravetta V; Agren H
Phys Chem Chem Phys; 2013 Jan; 15(1):244-54. PubMed ID: 23160171
[TBL] [Abstract][Full Text] [Related]
27. Towards in silico lead optimization: scores from ensembles of protein/ligand conformations reliably correlate with biological activity.
Popov VM; Yee WA; Anderson AC
Proteins; 2007 Feb; 66(2):375-87. PubMed ID: 17078091
[TBL] [Abstract][Full Text] [Related]
28. Calorimetric studies of ligand binding in R67 dihydrofolate reductase.
Jackson M; Chopra S; Smiley RD; Maynord PO; Rosowsky A; London RE; Levy L; Kalman TI; Howell EE
Biochemistry; 2005 Sep; 44(37):12420-33. PubMed ID: 16156655
[TBL] [Abstract][Full Text] [Related]
29. Quantum proton transfer in hydrated sulfuric acid clusters: a perspective from semiempirical path integral simulations.
Sugawara S; Yoshikawa T; Takayanagi T; Shiga M; Tachikawa M
J Phys Chem A; 2011 Oct; 115(42):11486-94. PubMed ID: 21910433
[TBL] [Abstract][Full Text] [Related]
30. Phthalide derivatives as dihydrofolate reductase inhibitors for malaria: molecular docking and molecular dynamics studies.
Ibraheem W; Makki AA; Alzain AA
J Biomol Struct Dyn; 2023 Jul; 41(11):5127-5137. PubMed ID: 35635144
[No Abstract] [Full Text] [Related]
31. Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase.
Schormann N; Velu SE; Murugesan S; Senkovich O; Walker K; Chenna BC; Shinkre B; Desai A; Chattopadhyay D
Bioorg Med Chem; 2010 Jun; 18(11):4056-66. PubMed ID: 20452776
[TBL] [Abstract][Full Text] [Related]
32. Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA.
Rastelli G; Del Rio A; Degliesposti G; Sgobba M
J Comput Chem; 2010 Mar; 31(4):797-810. PubMed ID: 19569205
[TBL] [Abstract][Full Text] [Related]
33. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
[TBL] [Abstract][Full Text] [Related]
34. Quantitative structure activity relationship study of 2,4,6-trisubstituted-s-triazine derivatives as antimalarial inhibitors of Plasmodium falciparum dihydrofolate reductase.
Ojha H; Gahlot P; Tiwari AK; Pathak M; Kakkar R
Chem Biol Drug Des; 2011 Jan; 77(1):57-62. PubMed ID: 20958921
[TBL] [Abstract][Full Text] [Related]
35. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
Fogel GB; Cheung M; Pittman E; Hecht D
J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
[TBL] [Abstract][Full Text] [Related]
36. The crystal structure of dihydrofolate reductase from Thermotoga maritima: molecular features of thermostability.
Dams T; Auerbach G; Bader G; Jacob U; Ploom T; Huber R; Jaenicke R
J Mol Biol; 2000 Mar; 297(3):659-72. PubMed ID: 10731419
[TBL] [Abstract][Full Text] [Related]
37. Vibrational softening of a protein on ligand binding.
Balog E; Perahia D; Smith JC; Merzel F
J Phys Chem B; 2011 Jun; 115(21):6811-7. PubMed ID: 21553905
[TBL] [Abstract][Full Text] [Related]
38. Changes in the electron density of the cofactor NADPH on binding to E. coli dihydrofolate reductase.
Bajorath J; Li ZQ; Fitzgerald G; Kitson DH; Farnum M; Fine RM; Kraut J; Hagler AT
Proteins; 1991; 11(4):263-270. PubMed ID: 1758881
[TBL] [Abstract][Full Text] [Related]
39. Thermodynamic and NMR analysis of inhibitor binding to dihydrofolate reductase.
Batruch I; Javasky E; Brown ED; Organ MG; Johnson PE
Bioorg Med Chem; 2010 Dec; 18(24):8485-92. PubMed ID: 21084197
[TBL] [Abstract][Full Text] [Related]
40. Nonclassical antifolates, part 4. 5-(2-aminothiazol-4-yl)-4-phenyl-4H-1,2,4-triazole-3-thiols as a new class of DHFR inhibitors: synthesis, biological evaluation and molecular modeling study.
Hassan GS; El-Messery SM; Al-Omary FA; Al-Rashood ST; Shabayek MI; Abulfadl YS; Habib el-SE; El-Hallouty SM; Fayad W; Mohamed KM; El-Menshawi BS; El-Subbagh HI
Eur J Med Chem; 2013 Aug; 66():135-45. PubMed ID: 23792351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
